FGF21 and metabolic dysfunction-associated steatohepatitis: Their results were also in accordance with the study conducted by Dushay et al. who reported lower hepatic FGF21 expression in NASH compared to NAFLD and suggested it may reflect more advanced hepatic injury (Dushay et al., 2010).